Sanofi Korea launches RSV preventive antibody Beyfortus
Sanofi Korea said it officially launched of Beyfortus (ingredient: nirsevimab) in Korea, marking the availability of the first respiratory syncytial virus (RSV) preventive antibody injection for all newborns and infants in the country. Beyfortus received …